Article Data

  • Views 862
  • Dowloads 151

Original Research

Open Access

Characteristics and prognostic factors of HIV-positive adults in the emergency department of a university hospital in South Korea, 2013–2022

  • Seojun Lee1
  • Chae Hyeon Lee2
  • Young Ju Suh3
  • Yu Jin Lee1
  • Ji Hye Kim1
  • Seung Baik Han1
  • Areum Durey1,*,

1Department of Emergency Medicine, Inha University School of Medicine, 22332 Incheon, Republic of Korea

2The Biomedical Center, Biomedical Research Institute, Inha University Hospital, 22332 Incheon, Republic of Korea

3Department of Biomedical Sciences, Inha University School of Medicine, 22212 Incheon, Republic of Korea

DOI: 10.22514/sv.2024.068 Vol.20,Issue 6,June 2024 pp.25-32

Submitted: 10 January 2024 Accepted: 12 March 2024

Published: 08 June 2024

*Corresponding Author(s): Areum Durey E-mail: areum.durey@inha.ac.kr

Abstract

An estimated 39 million individuals globally were living with human immunodeficiency virus (HIV) at the end of 2022 with approximately 1.3 million individuals newly infected during 2022. Similarly, the number of people living with HIV (PWH) has consistently increased in Korea and the number of PWH seeking emergency care is expected to increase. This study aimed to elucidate utilization patterns of emergency department (ED) of PWH and identify key indicators that predict admission and poor prognosis. This was a single-center retrospective study of HIV-positive adult patients who visited the ED between 01 January 2013 and 31 December 2022. Data was collected at the visit level and analyzed using the generalized estimating equation method. Visits were categorized into direct hospital admissions from the ED or discharges to home to evaluate admission-associated factors. Additionally, visits in the poor prognosis group were compared with the remainder to elucidate prognostic indicators. The poor prognosis group was defined as admitted visits with intensive care unit placement, visits with in-hospital mortality, or both. Annually, an average of 8.9 per 10,000 ED visits were made by PWH, with an admission rate of 49.8%. A total of 369 ED visits corresponding to 183 PWH were included in the analysis, and 93% of them were on highly active anti-retroviral therapy. Underlying chronic renal failure, presenting with fever or general weakness, supplemental oxygen administration, or ancillary department consultation in the ED increased admission odds. Ambulance use, high triage level and use of oxygen in the ED were associated with poor prognosis. Most notably, higher levels of blood urea nitrogen (BUN) or lactic acid were independent factors of poor prognosis. We hope these analytic insights from 10 years of institutional data will assist emergency physicians in providing timely informed care to HIV-infected individuals visiting the ED, ultimately leading to improved patient outcomes.


Keywords

Emergency department; HIV; Highly active antiretroviral therapy; Admission; Prognosis; South Korea


Cite and Share

Seojun Lee,Chae Hyeon Lee,Young Ju Suh,Yu Jin Lee,Ji Hye Kim,Seung Baik Han,Areum Durey. Characteristics and prognostic factors of HIV-positive adults in the emergency department of a university hospital in South Korea, 2013–2022. SignaVitae. 2024. 20(6);25-32.

References

[1] UNAIDS. 2023 UNAIDS global AIDS update. 2023. Available at: https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023 (Accessed: 14 February 2024).

[2] Korea Centers for Disease Control and Prevention. Annual report on the notified HIV/AIDS in Korea 2022. 2022. Available at: https://dportal.kdca.go.kr/pot/bbs/BD_selectBbs.do?q_bbsSn=1010&q_bbsDocNo=20230630735881389&q_clsfNo=1 (Accessed: 14 February 2024).

[3] Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2023; 329: 63–84.

[4] Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. The Lancet HIV. 2023; 10: e295–e307.

[5] Ng R, Kendall CE, Burchell AN, Bayoumi AM, Loutfy MR, Raboud J, et al. Emergency department use by people with HIV in Ontario: a population-based cohort study. CMAJ Open. 2016; 4: E240–E248.

[6] Mohareb AM, Rothman RE, Hsieh YH. Emergency department (ED) utilization by HIV-infected ED patients in the United States in 2009 and 2010—a national estimation. HIV Medicine. 2013; 14: 605–601.

[7] Abia A, Rothman RE, Mohareb AM, Lim GLH, Patel AV, Bigelow B, et al. Resource utilization across the continuum of HIV care: an emergency department-based cohort study. The American Journal of Emergency Medicine. 2021; 43: 164–169.

[8] Siddiqi KA, Liu Y, Ding DD, Olatosi BA. Estimating resource utilization for emergency department visits by patients’ HIV seropositivity in the United States, 2009 to 2018. The American Journal of Emergency Medicine. 2022; 53: 73–79.

[9] Hardin JW, Hilbe JM. Generalized estimating equations. 1st edition. Chapman & Hall/CRC: Boca Raton. 2002.

[10] Pirotte B, Frippiat F, Darcis G, Rassenfosse M, Fombellida K, Maes N, et al. Emergency department utilization by HIV-positive adults in a Belgian setting. The Medical Review of Liege. 2019; 74: 28–35. (In French)

[11] Venkat A, Shippert B, Hanneman D, Nesbit C, Piontkowsky DM, Bhat S, et al. Emergency department utilization by HIV-positive adults in the HAART era. International Journal of Emergency Medicine. 2008; 1: 287–296.

[12] Josephs JS, Fleishman JA, Korthuis PT, Moore RD, Gebo KA; HIV Research Network. Emergency department utilization among HIV-infected patients in a multisite multistate study. HIV Medicine. 2010; 11: 74–84.

[13] Cho Y, Chin B. Assessment of human immunodeficiency virus care continuum in Korea using the national health insurance system data. Infection & Chemotherapy. 2021; 53: 477–488.

[14] Choi JP. The HIV care cascade in Korea: status of UNAIDS 90-90-90 targets. Journal of Korean Medical Science. 2020; 35: e55.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top